{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:46:30Z","timestamp":1777880790272,"version":"3.51.4"},"reference-count":31,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Bayer S.p.A, Italy"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["SAGE Open Medicine"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Geffer effervescent granules (active ingredients: metoclopramide, dimethicone, and sodium bicarbonate) is an established over-the-counter medication available in Italy for the symptomatic treatment of hyperacidity (pain and\/or heartburn) when accompanied by slowing of gastric transit, nausea, aerophagia, and bloating, all symptoms that can occur in functional dyspepsia and can negatively impact individuals\u2019 quality of life. The aim of this observational study was to explore the perceived benefits of, and consumer experience with, Geffer effervescent granules used for the symptomatic treatment of digestive disorders suggestive of functional dyspepsia under real-life conditions in Italy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Adults (aged 35\u201365\u2009years) experiencing symptoms suggestive of functional dyspepsia\/indigestion at least once a month and who had used Geffer effervescent granules within the previous 6\u2009months completed an online questionnaire eliciting information on symptom relief (speed of onset and duration) and quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Geffer effervescent granules provided rapid onset of symptom relief, with 21% of respondents perceiving an effect within 10\u2009min and 88% reporting an improvement in overall symptoms within 30\u2009min. A similarly rapid onset of complete resolution of gastric pain\/cramps, acidity, bloating, nausea, and bothersome fullness symptoms was reported by 65%\u201383% of respondents; 50%\u201359% of respondents were free from such symptoms for more than 3\u2009h or until the next meal. Most participants (92%) reported that their quality of life improved when taking Geffer effervescent granules to treat hyperacidity symptoms. Overall, 95% of the respondents were satisfied with the effectiveness of Geffer effervescent granules on overall symptom relief.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In Italian consumers with digestive disorders likely due to functional dyspepsia, Geffer effervescent granules was associated with rapid, complete, and durable relief of symptoms of gastric pain\/cramps, acidity, bloating, nausea, and bothersome fullness; an improvement in quality of life; and a high level of consumer satisfaction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20503121221088815","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T07:50:18Z","timestamp":1648540218000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms"],"prefix":"10.1177","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5335-0907","authenticated-orcid":false,"given":"Matteo","family":"Alemanni","sequence":"first","affiliation":[{"name":"Bayer S.p.A., Milano, Italia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"de Salvo","sequence":"additional","affiliation":[{"name":"Bayer Consumer Care AG, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Moroni","sequence":"additional","affiliation":[{"name":"Bayer S.p.A., Milano, Italia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Ehret","sequence":"additional","affiliation":[{"name":"Bayer Consumer Care AG, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"key":"bibr1-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04564.x"},{"key":"bibr2-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00153-9"},{"issue":"1","key":"bibr3-20503121221088815","first-page":"18","volume":"66","author":"van Kerkhoven LA","year":"2008","journal-title":"Neth J Med"},{"key":"bibr4-20503121221088815","doi-asserted-by":"publisher","DOI":"10.3897\/pharmacia.68.e66065"},{"key":"bibr5-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.011"},{"key":"bibr6-20503121221088815","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.091"},{"key":"bibr7-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01897.x"},{"key":"bibr8-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.057"},{"key":"bibr9-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.078634"},{"key":"bibr10-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-018-0913-z"},{"key":"bibr11-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01042.x"},{"key":"bibr12-20503121221088815","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709011191"},{"key":"bibr13-20503121221088815","unstructured":"L\u2019Informatore Farmaceutico. Geffer, https:\/\/www.codifa.it\/farmaci\/g\/geffer-metoclopramide-e-dimeticone-e-potassio-citrato-e-acido-tartarico-e-acido-citrico-anidro-e-sodio-bicarbonato-procinetici (accessed 1 October 2021)."},{"key":"bibr14-20503121221088815","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199957060-00003"},{"key":"bibr15-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199012000-00005"},{"key":"bibr16-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(83)72633-7"},{"key":"bibr17-20503121221088815","unstructured":"PubChem. Metoclopromide, https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Metoclopramide (accessed 1 October 2021)."},{"key":"bibr18-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0b013e3182a2d896"},{"key":"bibr19-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-001-0332-1"},{"key":"bibr20-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.90"},{"key":"bibr21-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-017-0639-0"},{"key":"bibr22-20503121221088815","unstructured":"Ingold CJ, Akhondi H. Simethicone. In: StatPearls (Internet). Treasure Island, FL: StatPearls Publishing, 2021 (PMID: 32310457), https:\/\/pubmed.ncbi.nlm.nih.gov\/32310457\/"},{"key":"bibr23-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1177\/014107689008300907"},{"issue":"9","key":"bibr24-20503121221088815","first-page":"607","volume":"2","author":"Cobden I","year":"1981","journal-title":"Pharmatherapeutica"},{"key":"bibr25-20503121221088815","volume-title":"Sampling techniques","author":"Cochran WG","year":"1963","edition":"2"},{"key":"bibr26-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2006.01.024"},{"key":"bibr27-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328358bf74"},{"key":"bibr28-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04566.x"},{"key":"bibr29-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.10.007"},{"key":"bibr30-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1016\/0010-0285(86)90013-7"},{"key":"bibr31-20503121221088815","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.5502"}],"container-title":["SAGE Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20503121221088815","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20503121221088815","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20503121221088815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:22:10Z","timestamp":1777594930000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20503121221088815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":31,"alternative-id":["10.1177\/20503121221088815"],"URL":"https:\/\/doi.org\/10.1177\/20503121221088815","relation":{},"ISSN":["2050-3121","2050-3121"],"issn-type":[{"value":"2050-3121","type":"print"},{"value":"2050-3121","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"article-number":"20503121221088815"}}